AMGEN INC
AMGNAPI behind this page
AMGN Q2 2025 request
Playground key active
/api/financials?ticker=AMGN&year=2025&quarter=2
Pick an endpoint and run the request.Income Statement
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Revenue | 9,179 | 8,388 | +9.4% |
Show Product Lines breakouts |
|||
| Aranesp | 359 | 348 | +3.2% |
| Aranesp · Non Us | 252 | 257 | -1.9% |
| Aranesp · US | 107 | 91 | +17.6% |
| BLINCYTO | 384 | 264 | +45.5% |
| BLINCYTO · Non Us | 114 | 99 | +15.2% |
| BLINCYTO · US | 270 | 165 | +63.6% |
| ENBREL | 604 | 909 | -33.6% |
| ENBREL · Non Us | 7 | 7 | 0.0% |
| ENBREL · US | 597 | 902 | -33.8% |
| EVENITY | 518 | 391 | +32.5% |
| EVENITY · Non Us | 123 | 110 | +11.8% |
| EVENITY · US | 395 | 281 | +40.6% |
| KRYSTEXXA | 349 | 294 | +18.7% |
| KRYSTEXXA · US | 349 | 294 | +18.7% |
| KYPROLIS | 378 | 377 | +0.3% |
| KYPROLIS · Non Us | 146 | 137 | +6.6% |
| KYPROLIS · US | 232 | 240 | -3.3% |
| Nplate [Member] | 369 | 346 | +6.6% |
| Nplate [Member] · Non Us | 141 | 132 | +6.8% |
| Nplate [Member] · US | 228 | 214 | +6.5% |
| Otezla | 618 | 544 | +13.6% |
| Otezla · Non Us | 106 | 112 | -5.4% |
| Otezla · US | 512 | 432 | +18.5% |
| Other products | 1,690 | 1,326 | +27.5% |
| Other products · Non Us | 461 | 389 | +18.5% |
| Other products · US | 1,229 | 937 | +31.2% |
| Product | 8,771 | 8,041 | +9.1% |
| Product And Service Other | 408 | 347 | +17.6% |
| Product And Service Other · Reportable Segment | 408 | 347 | +17.6% |
| Product · Accumulated Gain Loss Net Cash Flow Hedge Parent | 12 | 55 | -78.2% |
| Product · Accumulated Gain Loss Net Cash Flow Hedge Parent | 12 | 55 | -78.2% |
| Product · Non Us | 2,447 | 2,201 | +11.2% |
| Product · Reportable Segment | 8,771 | 8,041 | +9.1% |
| Product · US | 6,324 | 5,840 | +8.3% |
| Prolia | 1,122 | 1,165 | -3.7% |
| Prolia · Non Us | 377 | 395 | -4.6% |
| Prolia · US | 745 | 770 | -3.2% |
| Repatha | 696 | 532 | +30.8% |
| Repatha · Non Us | 335 | 262 | +27.9% |
| Repatha · US | 361 | 270 | +33.7% |
| TEPEZZA | 505 | 479 | +5.4% |
| TEPEZZA · Non Us | 39 | 1 | +3800.0% |
| TEPEZZA · US | 466 | 478 | -2.5% |
| TEZSPIRE | 342 | 234 | +46.2% |
| TEZSPIRE · US | 342 | 234 | +46.2% |
| Vectibix | 305 | 270 | +13.0% |
| Vectibix · Non Us | 161 | 137 | +17.5% |
| Vectibix · US | 144 | 133 | +8.3% |
| XGEVA | 532 | 562 | -5.3% |
| XGEVA · Non Us | 185 | 163 | +13.5% |
| XGEVA · US | 347 | 399 | -13.0% |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 9,179 | 8,388 | +9.4% |
| Cost of Revenue | 3,011 | 3,236 | -7.0% |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 2,484 | 2,825 | -12.1% |
| Research And Development Expense Excluding Acquired In Process Cost | 1,744 | 1,447 | +20.5% |
| Selling, General & Administrative | 1,691 | 1,785 | -5.3% |
| Other General Expense | 77 | 11 | +600.0% |
| Total Costs & Expenses | 6,523 | 6,479 | +0.7% |
| Operating Income | 2,656 | 1,909 | +39.1% |
| Interest Expense Debt | -694 | -808 | +14.1% |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | -694 | -808 | +14.1% |
| Non-Operating Income (Expense) | -394 | -307 | -28.3% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Cross-currency swap contracts | 172 | -3 | +5833.3% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Cross-currency swap contracts | 172 | -3 | +5833.3% |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | 1,568 | 794 | +97.5% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income | 184 | 52 | +253.8% |
| Income Tax Expense (Benefit) | 136 | 48 | +183.3% |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 136 | 48 | +183.3% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income | 40 | 11 | +263.6% |
| Net Income | 1,432 | 746 | +92.0% |
Show Business Segments breakouts |
|||
| Reportable Segment | 1,432 | 746 | +92.0% |
| Reportable Segment · Operating Segments | 1,432 | 746 | +92.0% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income | 144 | 41 | +251.2% |
| Retained Earnings | 1,432 | 746 | +92.0% |
| EPS (Basic) | 2.66 | 1.39 | +91.4% |
| EPS (Diluted) | 2.65 | 1.38 | +92.0% |
| Wtd Avg Shares (Basic) | 538 | 537 | +0.2% |
| Wtd Avg Shares (Diluted) | 541 | 541 | 0.0% |
| Sales & Marketing (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 1,137 | 1,211 | -6.1% |
| General & Administrative (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 554 | 574 | -3.5% |
| Interest Income | 86 | 115 | -25.2% |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 86 | 115 | -25.2% |
| Comprehensive Income | 1,119 | 781 | +43.3% |
| Other Comprehensive Income | -313 | 35 | -994.3% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -313 | 35 | -994.3% |
| Depreciation And Amortization | 220 | 202 | +8.9% |
| Income Loss From Equity Method Investments (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 18 | -12 | +250.0% |
Balance Sheet
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 8,028 | 9,301 | -13.7% |
| Accounts Receivable | 8,701 | 6,934 | +25.5% |
| Inventory | 6,583 | 7,995 | -17.7% |
| Other Assets Current | 3,422 | 2,976 | +15.0% |
| Total Current Assets | 26,734 | 27,206 | -1.7% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 6,855 | 6,097 | +12.4% |
| Goodwill | 18,674 | — | — |
| Other Non-Current Assets | 11,020 | 8,816 | +25.0% |
| Total Assets | 87,897 | 90,907 | -3.3% |
| Intangible Assets | 23,904 | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Developed Technology Rights | 23,355 | — | — |
| Licensing Agreements | 418 | — | — |
| Research and development technology rights | 131 | — | — |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 24,614 | — | — |
Show Product Lines breakouts |
|||
| UPLIZNA · In Process Research And Development | 350 | — | — |
| Current Liabilities | |||
| Accounts Payable | 3,010 | 2,267 | +32.8% |
| Accrued Liabilities | 15,022 | 13,722 | +9.5% |
| Current Portion of Long-Term Debt | 2,444 | 5,528 | -55.8% |
| Total Current Liabilities | 20,476 | 21,517 | -4.8% |
| Non-Current Liabilities | |||
| Long-Term Debt | 53,760 | 57,117 | -5.9% |
| Deferred Tax Liabilities | 1,386 | 1,780 | -22.1% |
| Liability For Uncertain Tax Positions Noncurrent | 2,511 | 2,205 | +13.9% |
| Other Non-Current Liabilities | 2,336 | 2,363 | -1.1% |
| Long-Term Debt | 56,204 | 62,645 | -10.3% |
Show Long-Term Debt Type breakouts |
|||
| Notes Payable To Banks | 54.4 | — | — |
| Stockholders' Equity | |||
| Common Stocks Including Additional Paid In Capital | 33,680 | 33,204 | +1.4% |
| Retained Earnings | -25,708 | -27,124 | +5.2% |
| Accumulated Other Comprehensive Income | -544 | -155 | -251.0% |
| Total Stockholders' Equity | 7,428 | 5,925 | +25.4% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent | -335 | — | — |
| Accumulated Other Comprehensive Income | -544 | -155 | -251.0% |
| Accumulated Translation Adjustment | -231 | — | — |
| Common Stock Including Additional Paid In Capital | 33,680 | 33,204 | +1.4% |
| Other | 22 | — | — |
| Retained Earnings | -25,708 | -27,124 | +5.2% |
| Total Liabilities & Equity | 87,897 | 90,907 | -3.3% |
Cash Flow Statement
| Metric | YTD Q2 2025 | YTD Q2 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 2,728 | 2,799 | -2.5% |
| Impairment Of Intangible Assets Excluding Goodwill | 800 | 68 | +1076.5% |
| Stock-Based Compensation | 242 | 260 | -6.9% |
| Deferred Income Taxes And Tax Credits | -672 | -784 | +14.3% |
| Unrealized Gain Loss On Investments | -741 | 916 | -180.9% |
| Other Non-Cash Items | -73 | -174 | +58.0% |
| Change in Accounts Receivable | -1,823 | 310 | -688.1% |
| Change in Inventory | 527 | 1,528 | -65.5% |
| Increase Decrease In Other Operating Assets | -407 | -339 | -20.1% |
| Change in Accounts Payable | 1,086 | 666 | +63.1% |
| Increase Decrease In Accrued Income Taxes Payable | -2,313 | -1,311 | -76.4% |
| Increase Decrease In Noncurrent Tax Liability | 162 | -637 | +125.4% |
| Increase Decrease In Accrued Liabilities | -50 | -361 | +86.1% |
| Increase Decrease In Sales Incentives And Allowance | 1,113 | -393 | +383.2% |
| Increase Decrease In Other Operating Liabilities | -70 | -33 | -112.1% |
| Net Cash from Operations | 3,671 | 3,148 | +16.6% |
| Investing Activities | |||
| Capital Expenditures | -780 | -468 | -66.7% |
| Other Investing Activities | -56 | 34 | -264.7% |
| Net Cash from Investing | -836 | -434 | -92.6% |
| Financing Activities | |||
| Payments Of Debt Extinguishment Costs | -602 | -410 | -46.8% |
| Repayments Of Long Term Debt | -3,500 | -1,400 | -150.0% |
Show Debt Instrument breakouts |
|||
| Various Long-Term Notes · Notes Payable To Banks | -832 | -544 | -52.9% |
| Payments Of Dividends Common Stock | -2,559 | -2,417 | -5.9% |
| Proceeds From Payments For Other Financing Activities | -119 | -130 | +8.5% |
| Net Cash from Financing | -6,780 | -4,357 | -55.6% |
| Other Cash Flow | |||
| Net Change in Cash | -3,945 | -1,643 | -140.1% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 8,028 | 9,301 | -13.7% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.